Houde, V. P., Brûlé, S., Festuccia, W. T., Blanchard, P., Bellmann, K., Deshaies, Y., & Marette, A. (2010). Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue. American Diabetes Association.
Citação norma ChicagoHoude, Vanessa P., Sophie Brûlé, William T. Festuccia, Pierre-Gilles Blanchard, Kerstin Bellmann, Yves Deshaies, and André Marette. Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia By Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue. American Diabetes Association, 2010.
ציטוט MLAHoude, Vanessa P., et al. Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia By Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue. American Diabetes Association, 2010.